跳至主要内容
临床试验/CTRI/2025/02/080742
CTRI/2025/02/080742尚未招募不适用

Deploying Oncology Specific Telemedicine (TeleOPD) platform in the North- Eastern states of India a pilot study

National Cancer Grid1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年2月26日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
1.To establish telemedicine consultations for cancer care in rural and remote areas of North East India, utilizing NCG experts.

研究概览

简要总结

**Objective:**This pilot study aims to establish a telemedicine platform for cancer care in rural and remote areas of Northeast India, leveraging NCG experts and 10BedICU facilities. The goal is to improve access to specialized oncology consultations, reduce travel burdens, and streamline patient follow-ups.

Methodology:

  • Study Design: Prospective observational pilot study using a hub-and-spoke model.
  • Hub: Tata Memorial Hospital (TMH), Mumbai
  • Spokes: District hospitals in Churachandpur, Ukhrul, and Thoubal (Manipur)
  • Study Duration: 12 months
  • First 2 months: Recruitment & training of local healthcare providers
  • Month 3: Pilot run with dummy patients
  • Next 8 months: Live teleconsultations with real patients (~50 patients)
  • Final month: Data analysis & oncologist interviews
  • Participants: Adult cancer patients (new, follow-up, or seeking a second opinion).
  • Key Metrics:
  • Average consultation time
  • Provider & patient satisfaction scores
  • Teleconsultation failure rates

Expected Impact:

  • Improved cancer care accessibility in underserved regions
  • Reduced travel and financial burdens for patients
  • Enhanced coordination between primary care providers and oncology experts
  • Potential scalability to other National Cancer Grid (NCG) centers if successful

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients aged 18 years and above.
  • Patients who are willing to provide informed consent for participation in the study.
  • Patients who are able to communicate in the local language (Manipuri), Hindi/English.
  • Patients who are clinically stable and do not require emergency care.
  • Follow-up patients who have been treated at Tata Memorial Hospital (TMH) and are in remission at the last physical follow-up.
  • Patients who have completed treatment and are now on follow-up but have symptoms requiring examination.
  • New patients
  • Patients seeking a second opinion.

排除标准

  • 1.Patients who are unable to communicate effectively in the local language/Hindi/English.
  • 2.Patients with cognitive impairments that prevent them from understanding and following telemedicine instructions.

结局指标

主要结局

1.To establish telemedicine consultations for cancer care in rural and remote areas of North East India, utilizing NCG experts.

时间窗: Time point for first objective: 2 months | Time point for second objective: 1 month | Timepoint for third objective: 08 month

2.To develop and implement a training program for local healthcare providers on NCG guidelines and the use of the telemedicine platform.

时间窗: Time point for first objective: 2 months | Time point for second objective: 1 month | Timepoint for third objective: 08 month

3.To facilitate seamless coordination between primary care providers, local hospitals (spokes), and specialized center–Tata Memorial Hospital (the hub) for ongoing patient management and follow-up care of patients with cancer

时间窗: Time point for first objective: 2 months | Time point for second objective: 1 month | Timepoint for third objective: 08 month

次要结局

未报告次要终点

研究者

发起方
National Cancer Grid
申办方类型
Contract research organization
责任方
Principal Investigator
主要研究者

Dr Manju Sengar

Tata Memorial Hospital

研究点 (1)

Loading locations...

相似试验